Managing Critical Laboratory Values

1. Analyte and result — What is the critical value being reported? Default: not specified; flag [VERIFY].
2. Patient location — Inpatient (floor, ICU, ED, OR), outpatient clinic, or external provider? Default: inpatient.
3. Specimen integrity — Has the specimen been verified for hemolysis, clotting, or mislabeling before reporting as critical? Default: specimen verified.
4. Repeat confirmation — Has the critical value been repeated/verified per institutional policy before notification? Default: yes, per policy.
5. Responsible provider — Who is the ordering provider or covering clinician? Default: per LIS provider assignment.
6. Prior critical values — Has this patient had prior critical results for the same analyte? Default: no.
7. Time of result — When was the result generated? Default: current.

Documents to Request

• Laboratory result with critical value flag
• Institutional critical value list with defined thresholds
• Notification policy (who to call, escalation path, time limits)
• Specimen integrity assessment (hemolysis, clotting, collection site)
• Prior critical values for the same patient (trending)
• Documentation template for critical value notification
• Quality metrics dashboard for critical value reporting

Step 1: Critical Value Identification

Verify the result against the institutional critical value list. Common critical values per CAP/ASCP consensus:

Chemistry Critical Values

Hematology Critical Values

Microbiology / Blood Bank Critical Values

Step 2: Pre-Notification Verification

Before calling a critical value, verify:

1. Repeat testing: Per institutional policy, repeat the test on the same specimen (or from a fresh aliquot) to confirm the result. Exception: do not delay reporting of immediately life-threatening values (e.g., K > 7.0 mEq/L) for repeat — call immediately and repeat concurrently.
2. Specimen integrity: Check for hemolysis (falsely elevated K, LDH), clotting (falsely low platelets), lipemia (interference), underfill (coagulation), or IV contamination.
3. Patient identity: Verify the specimen label matches the patient record. A critical value on a mislabeled specimen is doubly dangerous.
4. Delta check: Compare to the patient's previous result. A sudden change (e.g., K from 4.0 to 7.2) may indicate specimen error rather than clinical change. Investigate before reporting if the delta is physiologically implausible.
5. Known status: Check if the patient is on dialysis (creatinine/potassium), anticoagulation therapy (INR/PTT), or chemotherapy (WBC/platelets) — the value may still be critical but the clinical team may already be aware.

Step 3: Notification Process

Execute the notification within the institutional time limit (typically 15-30 minutes from result verification):

Notification steps:

1. Call the ordering provider or covering clinician directly (not a unit clerk, not voicemail).
2. If the ordering provider is unreachable within 10 minutes, escalate per the notification chain: covering resident → attending → charge nurse → nursing supervisor → laboratory director.
3. Communicate using a structured format:
   • Patient name and identifiers
   • Test name and critical result value
   • Specimen type and collection time
   • Whether the result was repeat-confirmed
   • Any specimen integrity concerns
4. Read-back: The receiving clinician must read back the critical value to confirm accurate receipt per Joint Commission NPSG.
5. Document the notification immediately.

Special situations:

• Outpatient/external: Call the ordering provider's office. If unreachable, call the patient directly (if institutionally permitted) or route to an urgent care pathway.
• Operating room: Notify the anesthesiologist or circulating nurse. Do not page the surgeon during a procedure unless that is the only route.
• After hours: Use the on-call provider notification system. Never leave a critical value as a voicemail without live confirmation.

Step 4: Documentation Requirements

Document every critical value notification per CAP GEN.41329 and institutional policy:

Step 5: Quality Monitoring and Compliance Reporting

Track critical value notification performance metrics:

Key performance indicators:

• Notification time: Time from result verification to clinician notification (target: < 15-30 minutes per institutional policy).
• Compliance rate: Percentage of critical values with complete documentation (target: > 98%).
• Escalation rate: Frequency of escalation beyond primary provider (investigate if > 15%).
• Repeat critical rate: Frequency of repeat critical values on the same patient within 24 hours (may indicate inadequate clinical response or specimen issues).
• False critical rate: Critical values that were subsequently determined to be erroneous (specimen issues, instrument malfunction) — target: < 2%.

Report metrics monthly to laboratory leadership. Investigate individual cases where notification time exceeds the institutional threshold.

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Was the critical value verified by repeat testing or specimen integrity assessment before notification?
2. Was the notification made to a responsible licensed provider (not a clerk or voicemail)?
3. Was a read-back obtained and documented?
4. Is the complete notification documentation in the LIS (result, provider name, time, read-back)?
5. Was the notification completed within the institutional time limit?

Quality Audit

• Critical value identified against the institutional approved threshold list
• Repeat testing performed (or concurrent repeat initiated for immediately life-threatening values)
• Specimen integrity verified before notification (hemolysis, clotting, labeling)
• Delta check performed against previous patient results
• Notification made to a licensed responsible provider (not unit clerk)
• Read-back obtained and confirmed
• Notification completed within institutional time limit (typically 15-30 minutes)
• Complete documentation entered in LIS (result, provider, time, read-back, laboratorian)
• Escalation pathway followed when primary provider unreachable
• Outpatient critical values routed through appropriate notification pathway
• Monthly compliance metrics reviewed by laboratory leadership
• Individual cases exceeding time thresholds investigated with root cause analysis
• Critical value list reviewed and updated at least annually by laboratory director

Guidelines

• Never leave a critical value notification as a voicemail or written message without live verbal confirmation and read-back from a licensed provider
• Verify specimen integrity before reporting; a critically elevated potassium in a hemolyzed specimen should be investigated, not blindly reported as critical
• Do not delay notification of immediately life-threatening values (K > 7.0, glucose < 30, pH < 7.10) for repeat confirmation — call immediately and repeat concurrently
• Apply the institutional critical value list, which should be reviewed and approved annually by the laboratory director in collaboration with clinical leadership
• Document every element of the notification: who was called, when, what was communicated, who acknowledged, and whether read-back was confirmed
• Track notification times as a key quality metric; CAP expects laboratories to demonstrate continuous monitoring and improvement in critical value reporting timeliness
• For repeat critical values on the same patient within 24 hours, institutional policy should define whether re-notification is required (most institutions require re-notification unless the clinician has acknowledged awareness)
• Maintain the critical value list as a living document; review annually and update thresholds based on clinical consensus, patient population, and current medical evidence